Changes in heart rate in patients with type 2 diabetes mellitus after treatment with luseogliflozin: Subanalysis of placebo‐controlled, double‐blind clinical trials

por Sano, Motoaki, Chen, Shi, Imazeki, Hisae, Ochiai, Hidekazu, Seino, Yutaka
Publicado 2018

Sodium‐glucose cotransporter‐2 inhibitor luseogliflozin added to glucagon‐like peptide 1 receptor agonist liraglutide improves glycemic control with bodyweight and fat mass reducti...

por Seino, Yutaka, Yabe, Daisuke, Sasaki, Takashi, Fukatsu, Atsushi, Imazeki, Hisae, Ochiai, Hidekazu, Sakai, Soichi
Publicado 2017